GlucoSet

GlucoSet is a Norwegian medical technology company based in Trondheim, specializing in disposable intravascular glucose sensors for continuous glucose monitoring in critically ill patients, particularly in Intensive Care Units (ICUs). Founded in 2012, the company aims to enhance patient outcomes by providing accurate real-time glucose data, which helps clinicians maintain optimal glucose control and reduce the risk of complications and mortality. The core product of GlucoSet is a disposable glucose sensor that delivers continuous monitoring of blood glucose levels. This innovative technology is designed to address the needs of critically ill patients, a group that has been underserved by traditional glucose monitoring solutions. GlucoSet is supported by venture capital and has received funding from the European Union’s Horizon Europe program and the Norwegian Research Council, highlighting its commitment to research and development. With a dedicated team of researchers and medical professionals, GlucoSet fosters a collaborative work culture focused on innovation in healthcare. The company is positioned to make a significant impact in critical care through its advanced glucose monitoring technology.

• Employees 12
• Founded 2011
• Total Funding $9453907